Korro Bio, Inc.
KRRO
$13.35
$0.261.99%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -87.41M | -83.58M | -87.81M | -85.30M | -81.12M |
| Total Depreciation and Amortization | 4.06M | 3.57M | 3.30M | 3.35M | 3.55M |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 5.86M | 6.35M | 7.60M | 7.96M | 7.33M |
| Change in Net Operating Assets | 14.85M | 13.59M | 3.22M | 4.63M | 761.00K |
| Cash from Operations | -62.64M | -60.07M | -73.69M | -69.36M | -69.49M |
| Capital Expenditure | -12.41M | -17.90M | -18.11M | -13.47M | -11.93M |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -72.55M | -105.45M | -104.13M | -95.43M | 2.00M |
| Cash from Investing | -84.96M | -123.35M | -122.24M | -108.91M | -9.93M |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 69.39M | 69.36M | 222.63M | 222.11M | 154.64M |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | 0.00 | 0.00 | 0.00 |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -42.00K |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -9.62M | -12.02M | -12.10M |
| Cash from Financing | 69.39M | 69.36M | 213.01M | 210.09M | 142.50M |
| Foreign Exchange rate Adjustments | -4.00K | -4.00K | 2.00K | -- | -- |
| Miscellaneous Cash Flow Adjustments | 0.00 | 0.00 | -2.00K | -- | -- |
| Net Change in Cash | -78.21M | -114.07M | 17.09M | 31.82M | 63.08M |